Cincinnati, OH, United States of America

Mellikunja J Prakash

This inventor holds 1 USPTO granted patent. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mellikunja J Prakash. Retrieved from https://idiyas.com/inventor/mellikunja-j-prakash

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mellikunja J Prakash: Innovator in Purine Analogues

Introduction

Mellikunja J Prakash is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of purine analogues. His work focuses on creating compounds that can aid in the treatment of various diseases.

Latest Patents

Mellikunja J Prakash holds a patent for "5'-deoxy-5',5'-dihalo adenosines and purine analogues." This invention relates to certain 5',5'-dihaloaristeromycin/adenosine derivatives that are useful in inhibiting AdoMet-dependent transmethylation. These compounds have potential applications in treating patients afflicted with neoplastic or viral disease states. He has 1 patent to his name.

Career Highlights

Mellikunja J Prakash is associated with Merrell Dow Pharmaceuticals, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of purine derivatives and their therapeutic applications.

Collaborations

Some of his notable coworkers include Esa T Jarvi and James R McCarthy. Their collaborative efforts have further enhanced the research output and innovation at Merrell Dow Pharmaceuticals.

Conclusion

Mellikunja J Prakash is a distinguished inventor whose work in purine analogues has the potential to impact the treatment of serious health conditions. His contributions to medicinal chemistry continue to pave the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…